Price $15.84 |
Market Cap
107.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
11.7
|
P/B
0.8
|
P/S
1.23
|
Dividend %
-
|
|
P/CF
14.7
|
P/FCF
7.2
|
Op. Cash Flow
19.1K
|
FCF
2.2
|
|
Op. Margin
19.10%
|
Net Margin
10.70%
|
ROE
7.10%
|
ROI
9.30%
|
|
ROA
5.20%
|
EPS Growth
22.90%
|
Current Ratio
5.4
|
Debt/Equity
1.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Nascent Biotech Inc (NBIO) | $0.07 | - | - | 8.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.60 | - | - | 294.7M | Strong Buy |
| Generex Biotechnology Corporat (GNBT) | $0.08 | - | - | 18.7M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.20 | - | - | 31.3M | Strong Buy |
| Fuse Medical Inc (FZMD) | $0.53 | - | - | 52.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
